Suppr超能文献

出血性休克后肠系膜淋巴脂质通过磷脂酶A2使中性粒细胞致敏以增强细胞毒性。

Post-hemorrhagic shock mesenteric lymph lipids prime neutrophils for enhanced cytotoxicity via phospholipase A2.

作者信息

Gonzalez R J, Moore E E, Ciesla D J, Meng X, Biffl W L, Silliman C C

机构信息

Department of Surgery, Denver Health Medical Center, Colorado 80204, USA.

出版信息

Shock. 2001 Sep;16(3):218-22. doi: 10.1097/00024382-200116030-00008.

Abstract

Hemorrhagic shock induced mesenteric hypoperfusion has long been implicated as a key event in the pathogenesis of the adult respiratory distress syndrome (ARDS) and multiple organ failure (MOF). Previous work links post-hemorrhagic shock mesenteric lymph (PHSML) lipids and neutrophil (PMN) priming in the pathogenesis of ARDS. We hypothesize that gut phospholipase A2 (PLA2) liberates proinflammatory lipids following hemorrhagic shock, which are responsible for enhanced PMN cytotoxicity. Mesenteric lymph was collected from rats (n > or = 5) before hemorrhagic shock, during hemorrhagic shock (MAP 40 mm Hg x 30 min), and after resuscitation (shed blood + 2x lactated Ringers). PMNs were incubated with physiologic concentrations (1-5%, v:v) of (a) buffer control, (b) sham (c) pre-shock lymph, (c) PHSML, (d) PHSML lipid extracts, (e) heat-denatured PSHML, and (f) PHSML harvested after i.v. pretreatment with a known PLA2 inhibitor (quinacrine, 10 mg/kg). PMNs were activated with fMLP (1 micromol), and the maximal rate of superoxide production measured by reduction of cytochrome c. Gut morphology was assessed histologically using hematoxalin and eosin (HE) staining. PHSML and PHSML lipid extracts (5%, v:v) primed for enhanced superoxide production compared to buffer controls (2.5-fold and 3.6-fold), sham (2.5-fold) and pre-shock lymph (2.0-fold). Lymph collected after systemic PLA2 inhibition, in contrast, abrogated the PMN priming response. Gut mucosal morphology, at end-resuscitation, was intact on HE staining both with and without PLA2 inhibition. Heat denaturing the PHSML (eliminating cytokines and complement), on the other hand, did not reduce PMN priming. Physiologic concentrations of PHSML lipids prime the PMN respiratory burst. Lymph priming is diminished with systemic PLA2 inhibition, implicating gut PLA2 as a source of proinflammatory lipids that may be central in the pathogenesis of hemorrhagic shock induced ARDS/MOF.

摘要

长期以来,出血性休克引起的肠系膜灌注不足一直被认为是成人呼吸窘迫综合征(ARDS)和多器官功能衰竭(MOF)发病机制中的关键事件。先前的研究将出血性休克后肠系膜淋巴(PHSML)脂质与ARDS发病机制中的中性粒细胞(PMN)预激活联系起来。我们假设,肠道磷脂酶A2(PLA2)在出血性休克后释放促炎脂质,这些脂质导致PMN细胞毒性增强。在出血性休克前、出血性休克期间(平均动脉压40 mmHg,持续30分钟)以及复苏后(回输失血+2倍乳酸林格液),从大鼠(n≥5)收集肠系膜淋巴。将PMN与以下物质的生理浓度(1-5%,v:v)一起孵育:(a)缓冲液对照,(b)假手术组,(c)休克前淋巴,(c)PHSML,(d)PHSML脂质提取物,(e)热变性的PHSML,以及(f)经静脉注射已知PLA2抑制剂(奎纳克林,10 mg/kg)预处理后收集的PHSML。用fMLP(1 μmol)激活PMN,并通过细胞色素c还原测量超氧化物产生的最大速率。使用苏木精和伊红(HE)染色进行组织学评估肠道形态。与缓冲液对照(分别为2.5倍和3.6倍)、假手术组(2.5倍)和休克前淋巴(2.0倍)相比,PHSML和PHSML脂质提取物(5%,v:v)可引发超氧化物产生增强。相反,全身PLA2抑制后收集的淋巴消除了PMN预激活反应。在复苏结束时,无论有无PLA2抑制,HE染色显示肠道黏膜形态均完整。另一方面,热变性PHSML(消除细胞因子和补体)并未降低PMN预激活。生理浓度的PHSML脂质可引发PMN呼吸爆发。全身PLA2抑制可减少淋巴预激活,这表明肠道PLA2是促炎脂质的来源,可能在出血性休克诱导的ARDS/MOF发病机制中起核心作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验